Enveric Biosciences, Inc.
ENVB · NASDAQ
Bulios Fair Price
$1.03
32.2% downside
Current Price
$1.52
According to Bulios Fair Price, ENVB is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Enveric Biosciences Inc. (ENVB) is a biopharmaceutical company focused on developing innovative therapeutic products for the treatment of symptoms associated with cancer and other chronic diseases. The company specializes in the research and development of cannabinoid-based therapies and other natural compounds that offer patients hope for relief from pain, inflammation, and other challenges associated with illness.
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph Edward Tucker
Employees
6
Headquarters
Cambridge
Upcoming events
Earnings
Upcoming earnings report